Dynamic change of chromogranin A and synaptophysin in patients with pancreatic neuroendocrine tumor

Objective To investigate the dynamic changes of chromogranin A in patients with pancreatic neuroendocrine neoplasms after laparoscopic surgery, and to monitor the diagnosis and prognosis of patients with real-time monitoring. Methods Forty-five patients with pancreatic neuroendocrine neoplasms were enrolled in this study from March 2013 to March 2015 in First Hospita of Yulin City. All patients were underwent laparoscopic surgery. The surgical results were observed and the levels of postoperative chromogranin A were monitored. Comparisons between groups were evaluated with the χ2 test. Follow-up using telephone interview was performed to detect patients′ survival and up to January 2017. Results TNM patients with benign and malignant patients in the postoperative chromogranin A examination found that the positive expression rate were 85.0% and 53.0%, the difference between the two groups was statistically significant (P 0.05). Conclusion Endoscopic surgery for pancreatic neuroendocrine neoplasms is a minimally invasive, safe surgical approach, long-term survival rate of patients with the use of chromogranin A to monitor the level of patients after surgery can effectively assess the development and prognosis of the disease, but the synaptophysine has no significance in assessing the prognosis of the patient. Key words: Pancreatic neuroendocrine neoplasms; Chromogranin A; Laparoscopes; Prognosis